Silence Therapeutics Statistics
Total Valuation
SLN has a market cap or net worth of $977.63 million. The enterprise value is $781.98 million.
| Market Cap | 977.63M |
| Enterprise Value | 781.98M |
Important Dates
The next estimated earnings date is Wednesday, August 14, 2024, before market open.
| Earnings Date | Aug 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SLN has 46.58 million shares outstanding. The number of shares has increased by 10.24% in one year.
| Shares Outstanding | 46.58M |
| Shares Change (YoY) | +10.24% |
| Shares Change (QoQ) | +2.45% |
| Owned by Insiders (%) | 16.94% |
| Owned by Institutions (%) | 62.10% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 28.89 |
| Forward PS | n/a |
| PB Ratio | 6.14 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 23.10 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.82, with a Debt / Equity ratio of 0.00.
| Current Ratio | 12.82 |
| Quick Ratio | 11.35 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12.81 |
Financial Efficiency
Return on equity (ROE) is -80.70% and return on invested capital (ROIC) is -33.51%.
| Return on Equity (ROE) | -80.70% |
| Return on Assets (ROA) | -29.20% |
| Return on Capital (ROIC) | -33.51% |
| Revenue Per Employee | $310,598 |
| Profits Per Employee | -$410,950 |
| Employee Count | 109 |
| Asset Turnover | 0.22 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -7.80M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +291.60% in the last 52 weeks. The beta is 1.30, so SLN's price volatility has been higher than the market average.
| Beta (5Y) | 1.30 |
| 52-Week Price Change | +291.60% |
| 50-Day Moving Average | 20.54 |
| 200-Day Moving Average | 18.50 |
| Relative Strength Index (RSI) | 55.49 |
| Average Volume (20 Days) | 227,450 |
Short Selling Information
| Short Interest | 560,672 |
| Short Previous Month | 759,222 |
| Short % of Shares Out | 1.20% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.41 |
Income Statement
In the last 12 months, SLN had revenue of $33.86 million and -$44.79 million in losses. Loss per share was -$1.19.
| Revenue | 33.86M |
| Gross Profit | 23.68M |
| Operating Income | -53.52M |
| Pretax Income | -52.74M |
| Net Income | -44.79M |
| EBITDA | -48.33M |
| EBIT | -48.92M |
| Loss Per Share | -$1.19 |
Balance Sheet
The company has $196.48 million in cash and $356,284 in debt, giving a net cash position of $196.12 million or $4.21 per share.
| Cash & Cash Equivalents | 196.48M |
| Total Debt | 356,284 |
| Net Cash | 196.12M |
| Net Cash Per Share | $4.21 |
| Equity (Book Value) | 159.37M |
| Book Value Per Share | 3.42 |
| Working Capital | 215.52M |
Cash Flow
In the last 12 months, operating cash flow was -$50.41 million and capital expenditures -$23,152, giving a free cash flow of -$50.43 million.
| Operating Cash Flow | -50.41M |
| Capital Expenditures | -23,152 |
| Free Cash Flow | -50.43M |
| FCF Per Share | -$1.27 |
Margins
Gross margin is 69.94%, with operating and profit margins of -158.09% and -132.31%.
| Gross Margin | 69.94% |
| Operating Margin | -158.09% |
| Pretax Margin | -155.77% |
| Profit Margin | -132.31% |
| EBITDA Margin | -142.77% |
| EBIT Margin | -144.49% |
| FCF Margin | -148.96% |
Dividends & Yields
SLN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.24% |
| Shareholder Yield | -10.24% |
| Earnings Yield | -4.58% |
| FCF Yield | -5.16% |
Analyst Forecast
The average price target for SLN is $61.50, which is 193.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $61.50 |
| Price Target Difference | 193.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SLN has an Altman Z-Score of 4.8 and a Piotroski F-Score of 3.
| Altman Z-Score | 4.8 |
| Piotroski F-Score | 3 |